OSR HEALTH INC
OSRHNASDAQTrading Snapshot
- Day Range
- $0.08 β $0.26
- 52-Week Range
- $0.08 β $0.91
- Volume (shares)
- 26,396,831
- Avg Volume (shares)
- β
- Shares Outstanding
- 35.1M
- Next Earnings
- 2027-03-29
Fundamentals Snapshot
- Annual Revenue
- $3M
- Last Q Revenue
- $315,669
- P/E Ratio
- -0.0
- P/S Ratio
- 2.4x
- EPS (TTM)
- $-3.33
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.0%
OSR HEALTH INC
OSRHAbout OSR HEALTH INC
OSR Holdings, Inc. operates as a Special Purpose Acquisition Company (SPAC) β essentially a blank check entity. Its primary objective is to execute a substantial business combination, which may take the form of a merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or other comparable strategic transaction with one or more established businesses. The company was incorporated on February 25, 2020, and maintains its principal office in Bellevue, Washington.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
βLatest News & Updates

Reviewing Madrigal Pharmaceuticals (NASDAQ:MDGL) & OSR (NASDAQ:OSRH)
Madrigal Pharmaceuticals (NASDAQ: MDGL - Get Free Report) and OSR (NASDAQ: OSRH - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strengt

Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc.
NEW YORK CITY, NY / ACCESS Newswire / August 27, 2026 / Emerging Growth Research, LLC ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research flash report on OSR Health, Inc. (